Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8540)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2015 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Moran GW, Dubeau MF, Kaplan GG, Yang H, Eksteen B, Ghosh S, Panaccione R. Clinical predictors of thiopurine-related adverse events in Crohn's disease. World J Gastroenterol 2015; 21(25): 7795-7804 [PMID: 26167079 DOI: 10.3748/wjg.v21.i25.7795] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i25/7795.htm |
| Number | Citing Articles |
| 1 |
Frank DiPaola, Jean P. Molleston. Drug-Induced Liver Injury in Children. Current Hepatology Reports 2018; 17(3): 283 doi: 10.1007/s11901-018-0413-y
|
| 2 |
Matthew Hum, Muhammad N. Mahmood, Vivian Huang, Marlene Dytoc. Pancreatitis as a rare manifestation of Behçet disease. JAAD Case Reports 2017; 3(6): 470 doi: 10.1016/j.jdcr.2017.06.020
|
| 3 |
Aimee Alexoff, Grigory Roginsky, Ying Zhou, Michelle Kalenda, Kelly Minuskin, Eli D. Ehrenpreis. Inpatient Costs for Patients with Inflammatory Bowel Disease and Acute Pancreatitis. Inflammatory Bowel Diseases 2016; 22(5): 1095 doi: 10.1097/MIB.0000000000000739
|
| 4 |
Fernando Bermejo San José, Alicia Algaba, Sergio López Durán, Iván Guerra, Marta Aicart, María Hernández-Tejero, Elena Garrido, María de Lucas, Daniel Bonillo, Antonio López Sanromán. Mercaptopurine and inflammatory bowel disease: the other thiopurine. Revista Española de Enfermedades Digestivas 2016; 109 doi: 10.17235/reed.2016.4546/2016
|
| 5 |
Shailesh Perdalkar, Pooja Basthi Mohan, Balaji Musunuri, Siddheesh Rajpurohit, Shiran Shetty, Krishnamurthy Bhat, Cannanore Ganesh Pai. Thiopurine therapy in inflammatory bowel disease in the pandemic era: Safe or unsafe?. International Immunopharmacology 2023; 116: 109597 doi: 10.1016/j.intimp.2022.109597
|
| 6 |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
|
| 7 |
Fenna M. Jansen, Lisa J. T. Smits, Pepijn W. A. Thomas, Dirk J. de Jong, Joany E. Kreijne, Willemijn A. van Dop, Nathan den Broeder, Frank Hoentjen. Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy. Digestive Diseases and Sciences 2023; 68(7): 2936 doi: 10.1007/s10620-023-07950-0
|
| 8 |
Bálint Tél, Bence Stubnya, Noémi Gede, Péter Varjú, Zoltán Kiss, Katalin Márta, Péter Jenő Hegyi, András Garami, Eszter Hegyi, Zsolt Szakács, Péter Hegyi, Gábor Veres. Inflammatory Bowel Diseases Elevate the Risk of Developing Acute Pancreatitis. Pancreas 2020; 49(9): 1174 doi: 10.1097/MPA.0000000000001650
|
| 9 |
Claudio Ponticelli, Richard J. Glassock. Prevention of complications from use of conventional immunosuppressants: a critical review. Journal of Nephrology 2019; 32(6): 851 doi: 10.1007/s40620-019-00602-5
|
| 10 |
Keizo Zeze, Atsushi Hirano, Takehiro Torisu, Motohiro Esaki, Tomohiko Moriyama, Junji Umeno, Keisuke Kawasaki, Shin Fujioka, Yuta Fuyuno, Yuichi Matsuno, Takanari Kitazono. Adding Thiopurine After Loss of Response to Infliximab Versus Early Combination in Treating Crohn’s Disease: A Retrospective Study. Digestive Diseases and Sciences 2021; 66(9): 3124 doi: 10.1007/s10620-020-06600-z
|
| 11 |
Linda A. Feagins, Sunanda V. Kane. Caring for Women with Inflammatory Bowel Disease. Gastroenterology Clinics of North America 2016; 45(2): 303 doi: 10.1016/j.gtc.2016.02.007
|
| 12 |
Rahul Shukla. Drug Design - Novel Advances in the Omics Field and Applications. 2021; doi: 10.5772/intechopen.93737
|
| 13 |
X. Zhu, X.‐D. Wang, K. Chao, M. Zhi, H. Zheng, H.‐L. Ruan, S. Xin, N. Ding, P.‐J. Hu, M. Huang, X. Gao. NUDT15 polymorphisms are better than thiopurine S‐methyltransferase as predictor of risk for thiopurine‐induced leukopenia in Chinese patients with Crohn's disease. Alimentary Pharmacology & Therapeutics 2016; 44(9): 967 doi: 10.1111/apt.13796
|
| 14 |
Igor G. Bakulin, Maria I. Skalinskaya, Igor V. Maev, Ekaterina V. Skazyvaeva, Mariia S. Zhuravleva, Larisa B. Gaikovaya, Natalia V. Bakulina, Aleksei I. Ermakov, Ekaterina S. Alekseenko, Kristina N. Ivanova, Mikhail V. Solovev. Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management. Terapevticheskii arkhiv 2021; 93(8): 841 doi: 10.26442/00403660.2021.08.200982
|
| 15 |
Ji Young Chang, Jae Hee Cheon. Thiopurine Therapy in Patients With Inflammatory Bowel Disease: A Focus on Metabolism and Pharmacogenetics. Digestive Diseases and Sciences 2019; 64(9): 2395 doi: 10.1007/s10620-019-05720-5
|
| 16 |
Dunja Urbančič, Flaka Pasha, Alenka Šmid, Irena Mlinarič-Raščan. Personalization of thiopurine therapy: Current recommendations and future perspectives. Acta Pharmaceutica 2024; 74(3): 355 doi: 10.2478/acph-2024-0030
|
| 17 |
Kirby Welston, Dianne May. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2016; 38: 379 doi: 10.1016/bs.seda.2016.08.012
|
| 18 |
Hai Yun Shi, Siew Chien Ng. The state of the art on treatment of Crohn’s disease. Journal of Gastroenterology 2018; 53(9): 989 doi: 10.1007/s00535-018-1479-6
|
| 19 |
Dana Duricova, Benjamin Pariente, Hélène Sarter, Mathurin Fumery, Ariane Leroyer, Cloe Charpentier, Laura Armengol-Debeir, Laurent Peyrin-Biroulet, Guillaume Savoye, Corinne Gower-Rousseau. Impact of age at diagnosis on natural history of patients with elderly-onset ulcerative colitis: A French population-based study. Digestive and Liver Disease 2018; 50(9): 903 doi: 10.1016/j.dld.2018.04.011
|
| 20 |
Bhairavi Balram, Joshua Lubov, Yves Theoret, Waqqas Afif, Alain Bitton, Gary Wild, Peter L. Lakatos, Talat Bessissow. Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy. Digestive Diseases and Sciences 2021; 66(5): 1650 doi: 10.1007/s10620-020-06427-8
|
| 21 |
Calvin J. Meaney, Spinel Karas. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2016; 38: 407 doi: 10.1016/bs.seda.2016.08.001
|
| 22 |
Kalle Landerholm, Disa Kalman, Conny Wallon, Pär Myrelid. Immunomodulators: Friends or Enemies in Surgery for Crohn’s Disease?. Current Drug Targets 2019; 20(13): 1384 doi: 10.2174/1389450120666190617163919
|
| 23 |
Margalida Calafat, Míriam Mañosa, Fiorella Cañete, Elena Ricart, Eva Iglesias, Marta Calvo, Francisco Rodríguez‐Moranta, Carlos Taxonera, Pilar Nos, Francisco Mesonero, María-Dolores Martín‐Arranz, Miguel Mínguez, Javier P. Gisbert, Santiago García‐López, Ruth de Francisco, Fernando Gomollón, Xavier Calvet, Esther Garcia‐Planella, Montserrat Rivero, Jesús Martínez‐Cadilla, Federico Argüelles, Lara Arias, Marta Cimavilla, Yamile Zabana, Eugeni Domènech. Increased risk of thiopurine‐related adverse events in elderly patients with IBD. Alimentary Pharmacology & Therapeutics 2019; 50(7): 780 doi: 10.1111/apt.15458
|
| 24 |
Anke L. H. Nguyen, Miles P. Sparrow. Evolving Role of Thiopurines in Inflammatory Bowel Disease in the Era of Biologics and New Small Molecules. Digestive Diseases and Sciences 2021; 66(10): 3250 doi: 10.1007/s10620-020-06662-z
|
| 25 |
Fabio Salvatore Macaluso, Sara Renna, Marcello Maida, Mariangela Dimarco, Chiara Sapienza, Marco Affronti, Emanuele Orlando, Giulia Rizzuto, Rosalba Orlando, Marco Ventimiglia, Mario Cottone, Ambrogio Orlando. Tolerability profile of thiopurines in inflammatory bowel disease: a prospective experience. Scandinavian Journal of Gastroenterology 2017; : 1 doi: 10.1080/00365521.2017.1333626
|
| 26 |
Cristina Suárez Ferrer, Yago González-Lama, Irene González-Partida, Marta Calvo Moya, Isabel Vera Mendoza, Virginia Matallana Royo, Juan Arevalo Serrano, Luis Abreu Garcia. Usefulness of Thiopurine Monotherapy for Crohn’s Disease in the Era of Biologics: A Long-Term Single-Center Experience. Digestive Diseases and Sciences 2019; 64(3): 875 doi: 10.1007/s10620-018-5381-0
|
| 27 |
Femke Crouwel, Ahmed B Bayoumy, Chris J J Mulder, Job H C Peters, Paul J Boekema, Luc J J Derijks, Sybrand Y de Boer, Paul C van de Meeberg, Ishfaq Ahmad, Hans J C Buiter, Nanne K de Boer. The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naïve Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases 2024; 30(9): 1492 doi: 10.1093/ibd/izad197
|
| 28 |
Alexander T. Elford, Stephanie Dimovski, Britt Christensen. Tricks and traps of thioguanine: a case report of myelotoxicity. Internal Medicine Journal 2023; 53(6): 1089 doi: 10.1111/imj.16113
|